Shah S, Sesti AM, Copley-Merriman K, Clark M. Summary of quality of life labeling components in the package inserts. Poster presented at the DIA-QOL Meeting; March 2002.
Cella D, Eton DT, Faircloth DL, Bonomi P, Heyes AE, Silberman C, Wolf MK, Johnson DH. What is a clinically meaningful change on the Functional Assessment of Cancer Therapy - Lung (FACT-L) questionnaire? Results from Eastern Cooperative Group (ECOG) Study 5592. J Clin Epidemiol. 2002 Mar;55(3):285-95.
Menter A, Gottlieb A, Griffiths C, Mordin MM. Health-related quality of life impact of weekly intravenous or intramuscular alefacept in patients with psoriasis: results from two randomized, placebo-controlled phase III trials. Poster presented at the Annual Meeting of the American Academy of Dermatology; February 2002.
Santanello NC, Baker D, Cappelleri JC, Copley-Merriman K, DeMarinis R, Gagnon JP, Hsuan A, Jackson J, Mahmoud R, Miller D, Morgan M, Osterhaus J, Tilson H, Willke R. Regulatory issues for health-related quality of life—PhRMA Health Outcomes Committee Workshop, 1999. Value Health. 2002 Jan;5(1):14-25.
Leidy NK, Jonas D, Silberman C, Heyes AE. What role do symptoms play in health-related quality of life? Poster presented at the 8th Annual Conference of the International Society for Quality of Life Research; November 2001. Amsterdam, The Netherlands.
Jonas D, Leidy NK, Silberman C, Margolis MK, Heyes AE. Cognitive factors in symptom assessment: are we asking too much? Poster presented at the 8th Annual Conference of the International Society for Quality of Life Research; November 2001. Amsterdam, The Netherlands.
Sorensen SV, Chambers M, Heyes AE. An economic model for the pharmacological management of advanced non-small cell lung cancer in the US. Poster presented at the International Society for Pharmacoeconomics and Outcomes Research; 2001. Cannes, France. [abstract] Value Health. 2001 Sep; 4(6):403.
Njue AI, Feng X-P, Prichard RK. Ivermectin resistance and the glutamate-gated chloride channels in the cattle nematode cooperia oncophora. Poster presented at the 18th International Conference of the World Association for the Advancement of Veterinary Parasitology; August 2001.
Buchner DA, Graboys TB, Johnson K, Mordin MM, Goodman L, Partsch DS, Goss TF. Development and validation of the ITG Health-Related Quality-of- Life Short-Form measure for use in patients with coronary artery disease. Integrated Therapeutics Group. Clin Cardiol. 2001 Aug;24(8):556-63.
Yang J, Bogerd HP, Wang PJ, Page DC, Cullen BR. Two closely related human nuclear export factors utilize entirely distinct export pathways. Mol Cell. 2001 Aug;8(2):397-406.
Shah S, Sesti AM, Chopra T, McLaughlin-Miley C, Copley-Merriman K. Quality of life terminology documented in package inserts. Mapi Quality of Life Newsletter. 2001 Jul;27:1-3.
Njue AI, Prichard RK. Ivermectin resistance in cooperia oncophora and beta-tubulin. Poster presented at the 46th Annual Meeting of the American Association of Veterinary Parasitologists; July 2001.
Anderson H, Espinosa E, Lofts F, Meehan M, Hutchinson G, Price N, Heyes AE. Evaluation of the Chemotherapy Patient Monitor: an interactive tool for facilitating communication between patients and oncologists during the cancer consultation. Eur J Cancer Care (Engl). 2001 Jun;10(2):115-23.
Cella D, Eton DT, Fairclough DL, Heyes AE, Silberman C, Wolf MK. What is a clinically meaningful change (CMC) on the functional assessment of cancer therapy - lung (FACT-L): analysis of ecog 5592 data. Poster presented at the 37th Annual Meeting of the American Society of Clinical Oncology; May 2001. San Francisco, CA.
Cella D, Eton DT, Fairclough DL, Heyes AE, Silberman C, Wolf MK. What is a clinically meaningful change (CMC) on the Functional Assessment of Cancer Therapy - Lung (FACT-L): analysis of ECOG 5592 data. Poster presented at the 7th Central European Lung Cancer Conference; June 2001. Prague, Czech Republic. [abstract] Lung Cancer. 2001 May; 32(Suppl 1):52.
Leidy NK, Jonas D, Margolis MK, Heyes AE, Jones K, Silberman C. On health-related quality of life, symptoms and the complementary nature of two patient-reported outcomes. Presented at the Drug Information Association Symposium of Contributed Papers on Quality of Life Evaluation; March 2001. Hilton Head, SC.
Cella D, Eton DT, Fairclough DL, Heyes AE, Silberman C, Bonomi P, Wolf MK. What is a clinically meaningful change (CMC) on the Functional Assessment of Cancer Therapy (lung) (FACT-L): analysis of ECOG 5592 data. Lung Cancer. 2001;373-6.
Yang J, Bogerd HP, Le S, Cullen BR. The human endogenous retrovirus K Rev response element coincides with a predicted RNA folding region. RNA. 2000 Nov;6:1551-64.
Bogerd HP, Wiegand HL, Yang J, Cullen BR. Mutational definition of functional domains within the Rev homolog encoded by human endogenous retrovirus K. J Virol. 2000 Oct;74(20):9353-61.
Njue AI, Prichard RK. Cloning a glutamate-gated chloride channel gene homologue from the cattle nematode cooperia oncophora. Poster presented at the 45th Annual Meeting of the American Association of Veterinary Parasitologists; July 2000.
Sesti A, Albright A, McLaughlin-Miley A, Copley-Merriman K. A methodology to measure productivity of health outcomes groups. Poster presented at the International Society for Pharmacoeconomics and Outcomes Research; May 2000.
Wang A, Graham L, Copley-Merriman K. Treatment satisfaction in outcomes research: an overview of study measures. Poster presented at the International Society for Pharmacoeconomics and Outcomes Research; May 2000.
Sculpher M, Palmer MK, Heyes AE. Costs incurred by patients undergoing advanced colorectal cancer therapy. A comparison of raltitrexed and fluorouracil plus folinic acid. Pharmacoeconomics. 2000 Apr;17(4):361-70.
McGrath M. Issues in designing, selecting, and interpreting a quality of life instrument. Poster presented at the Outcomes Research & Design Conference; March 2000.
Caro JJ, Klittich WS, Raggio G, Kavanagh PL, O'Brien JA, Shomphe LA, Flegel KM, Copley-Merriman C, Sigler C. Economic assessment of troglitazone as an adjunct to sulfonylurea therapy in the treatment of type 2 diabetes. Clin Ther. 2000 Jan;22(1):116-27.
Yang J, Cullen BR. Structural and functional analysis of the avian leukemia virus constitutive transport element. RNA. 1999 Dec;5:1645-55.
Yang J, Bogerd HP, Peng S, Wiegand H, Truant R, Cullen BR. An ancient family of human endogenous retroviruses encodes a functional homolog of the HIV-1 Rev protein. Proc Natl Acad Sci U S A. 1999 Nov 9;96(23):13404-8.
Kang Y, Bogerd HP, Yang J, Cullen BR. Analysis of the RNA binding specificity of the human tap protein, a constitutive transport element-specific nuclear RNA export factor. Virol J. 1999 Sep 15;262(1):200-9. doi: 10.1006/viro.1999.9906
Yang J, Eickbush TH. RNA-induced changes in the activity of the endonuclease encoded by the R2 retrotransposable element. Mol Cell Biol. 1998 Jun;18(6):3455-65.
Yang J, Malik HS, Eickbush TH. Identification of the endonuclease domain encoded by R2 and other site-specific, non-long terminal repeat retrotransposable elements. Proc Natl Acad Sci U S A. 1996 Jul 6;96(14):7847-52.
Burudi EM, Karanja SM, Njue AI, Githiori JB, Ndung'u JM. Establishment of a partly DFMO-sensitive primate model of Trypanosoma rhodesiense sleeping sickness. Acta Trop. 1995 Mar;59(1):71-3.
Richards EJ, Vongs A, Walsh M, Yang J, Chao S. Substructure of telomere repeat arrays. In: Flavell RB, Heslop‐Harrison JS, editors. The Chromosome. Oxford: United Kingdom. Bios Scientific Publishers; 1993.
Richards EJ, Chao S, Vongs A, Yang J. Characterization of Arabidopsis thaliana telomeres isolated in yeast. Nucleic Acid Res. 1992 Aug 11;20(15):4039-46.